NCT01701024View on ClinicalTrials.gov

Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne

PHASE3CompletedINTERVENTIONAL
Enrollment

498

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2013

Conditions
Acne
Interventions
DRUG

ACYC

ACYC active, topically applied to the face for 12 weeks

DRUG

ACYC vehicle

ACYC vehicle (placebo), topically applied to the face for 12 weeks

Trial Locations (24)

14623

Rochester

23507

Norfolk

24501

Lynchburg

27612

Raleigh

33180

Aventura

36608

Mobile

37072

Goodlettsville

40202

Louisville

46617

South Bend

47714

Evansville

48038

Clinton Township

55432

Fridley

60563

Naperville

68144

Omaha

77056

Houston

77845

College Station

78250

San Antonio

78759

Austin

84117

Salt Lake City

87106

Albuquerque

90045

Los Angeles

92123

San Diego

97210

Portland

06511

New Haven

Sponsors
All Listed Sponsors
collaborator

Dow Pharmaceutical Sciences

INDUSTRY

lead

Bausch Health Americas, Inc.

INDUSTRY